ALDH1A3 and Guillain-Barre syndrome: Recent studies indicate that ALDH1A1 or ALDH1A3 expression may be associated with distinct molecular subtypes of GB, with ALDH1A3 being the mesenchymal subtype [15,16,18] and ALDH1A1 associated with classical GBs [13], showing a better response to combined radiochemotherapy compared to mesenchymal GBs [19].